Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety, Effectiveness, and Pharmacokinetics of Boya Intravenous Immune Globulin in Patients With Primary Immune Deficiency.

NCT06150833 is registered in ClinicalTrials.gov with Azidus Brasil as lead sponsor.

NCT NCT06150833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06150833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety, Effectiveness, and Pharmacokinetics of Boya Intravenous Immune Globulin in Patients With Primary Immune Deficiency.
Lead sponsor
Azidus Brasil
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
September 30, 2028
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary immunodeficiency disease